questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines mitochondriales
Protéines de transport de la membrane mitochondriale
Protéines de découplage mitochondrial
Protéines de découplage mitochondrial : Questions médicales fréquentes
Termes MeSH sélectionnés :
Molecular Docking Simulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de découplage mitochondrial : Questions médicales les plus fréquentes",
"headline": "Protéines de découplage mitochondrial : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de découplage mitochondrial : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de découplage mitochondrial"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de transport de la membrane mitochondriale",
"url": "https://questionsmedicales.fr/mesh/D033681",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de transport de la membrane mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D033681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine-1 de découplage",
"alternateName": "Uncoupling Protein 1",
"url": "https://questionsmedicales.fr/mesh/D000071256",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-2 de découplage",
"alternateName": "Uncoupling Protein 2",
"url": "https://questionsmedicales.fr/mesh/D000071246",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-2 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 de découplage",
"alternateName": "Uncoupling Protein 3",
"url": "https://questionsmedicales.fr/mesh/D000071247",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de découplage mitochondrial",
"alternateName": "Mitochondrial Uncoupling Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000071245",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Colin J Barnstable",
"url": "https://questionsmedicales.fr/author/Colin%20J%20Barnstable",
"affiliation": {
"@type": "Organization",
"name": "Department of Neural and Behavioral Sciences, The Pennsylvania State University, Hershey, PA, 17033, USA. Electronic address: cbarnstable@pennstatehealth.psu.edu."
}
},
{
"@type": "Person",
"name": "Elena A Kotova",
"url": "https://questionsmedicales.fr/author/Elena%20A%20Kotova",
"affiliation": {
"@type": "Organization",
"name": "Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia."
}
},
{
"@type": "Person",
"name": "Yuri N Antonenko",
"url": "https://questionsmedicales.fr/author/Yuri%20N%20Antonenko",
"affiliation": {
"@type": "Organization",
"name": "Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. antonen@belozersky.msu.ru."
}
},
{
"@type": "Person",
"name": "Ljudmila S Khailova",
"url": "https://questionsmedicales.fr/author/Ljudmila%20S%20Khailova",
"affiliation": {
"@type": "Organization",
"name": "Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia."
}
},
{
"@type": "Person",
"name": "Elena E Pohl",
"url": "https://questionsmedicales.fr/author/Elena%20E%20Pohl",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences, Institute of Physiology, Pathophysiology and Biophysics, University of Veterinary Medicine, 1210 Vienna, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.",
"datePublished": "2022-08-26",
"url": "https://questionsmedicales.fr/article/36026508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0268269"
}
},
{
"@type": "ScholarlyArticle",
"name": "Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38773273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-62520-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation.",
"datePublished": "2024-09-06",
"url": "https://questionsmedicales.fr/article/39243097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41065-024-00334-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/38981921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00894-024-06060-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37453331",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2023.136836"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines mitochondriales",
"item": "https://questionsmedicales.fr/mesh/D024101"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de transport de la membrane mitochondriale",
"item": "https://questionsmedicales.fr/mesh/D033681"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de découplage mitochondrial",
"item": "https://questionsmedicales.fr/mesh/D000071245"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de découplage mitochondrial - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de découplage mitochondrial",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de découplage mitochondrial",
"description": "Comment diagnostiquer une dysfonction des UCP ?\nQuels tests sont utilisés pour évaluer les UCP ?\nLes biopsies musculaires sont-elles utiles ?\nQuels symptômes peuvent indiquer un problème d'UCP ?\nLes tests génétiques sont-ils fiables ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Molecular+Docking+Simulation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de découplage mitochondrial",
"description": "Quels sont les symptômes d'une suractivité des UCP ?\nComment une sous-activité des UCP se manifeste-t-elle ?\nLes UCP affectent-ils la température corporelle ?\nY a-t-il des symptômes neurologiques associés ?\nLes UCP influencent-elles le métabolisme des lipides ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Molecular+Docking+Simulation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de découplage mitochondrial",
"description": "Comment prévenir les dysfonctionnements des UCP ?\nLe stress oxydatif affecte-t-il les UCP ?\nLes antioxydants aident-ils à protéger les UCP ?\nL'alimentation influence-t-elle la santé mitochondriale ?\nLe tabagisme affecte-t-il les UCP ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Molecular+Docking+Simulation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de découplage mitochondrial",
"description": "Quels traitements ciblent les UCP ?\nL'exercice physique aide-t-il à réguler les UCP ?\nLes suppléments nutritionnels sont-ils bénéfiques ?\nY a-t-il des traitements expérimentaux ?\nComment la diète influence-t-elle les UCP ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Molecular+Docking+Simulation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de découplage mitochondrial",
"description": "Quelles complications peuvent survenir avec des UCP dysfonctionnelles ?\nLes UCP sont-elles liées à l'obésité ?\nLes maladies neurodégénératives sont-elles associées aux UCP ?\nLes UCP affectent-elles la santé cardiaque ?\nY a-t-il un lien entre UCP et diabète ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Molecular+Docking+Simulation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de découplage mitochondrial",
"description": "Quels facteurs de risque influencent les UCP ?\nL'âge affecte-t-il la fonction des UCP ?\nLes maladies génétiques influencent-elles les UCP ?\nLe mode de vie sédentaire impacte-t-il les UCP ?\nLe stress psychologique influence-t-il les UCP ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Molecular+Docking+Simulation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des UCP ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses biochimiques des mitochondries peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les UCP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la mesure de la respiration mitochondriale et l'analyse des métabolites."
}
},
{
"@type": "Question",
"name": "Les biopsies musculaires sont-elles utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'évaluer la fonction mitochondriale et les niveaux d'UCP."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'UCP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, intolérance à l'exercice et troubles métaboliques peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations spécifiques liées aux UCP."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une suractivité des UCP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut entraîner une perte de poids et une intolérance au froid."
}
},
{
"@type": "Question",
"name": "Comment une sous-activité des UCP se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut causer une prise de poids, une fatigue accrue et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les UCP affectent-ils la température corporelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles jouent un rôle dans la thermogenèse et la régulation de la température."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et des douleurs neuropathiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les UCP influencent-elles le métabolisme des lipides ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans la régulation du métabolisme lipidique et glucidique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des UCP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice régulier."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif affecte-t-il les UCP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut altérer la fonction des UCP, donc le réduire est crucial."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à protéger les UCP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire les dommages mitochondriaux et soutenir les UCP."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé mitochondriale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments favorise la santé mitochondriale et les UCP."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les UCP ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut nuire à la fonction mitochondriale et aux UCP."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les UCP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agonistes des UCP et des interventions diététiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à réguler les UCP ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice peut améliorer la fonction mitochondriale et l'activité des UCP."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels sont-ils bénéfiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antioxydants et des acides gras oméga-3 peuvent soutenir la fonction des UCP."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des modulateurs de l'UCP sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Comment la diète influence-t-elle les UCP ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diète riche en acides gras insaturés peut stimuler l'activité des UCP."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des UCP dysfonctionnelles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, des maladies cardiovasculaires et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les UCP sont-elles liées à l'obésité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction des UCP peut contribuer à l'obésité et à la résistance à l'insuline."
}
},
{
"@type": "Question",
"name": "Les maladies neurodégénératives sont-elles associées aux UCP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des UCP peuvent être impliquées dans des maladies comme Alzheimer."
}
},
{
"@type": "Question",
"name": "Les UCP affectent-elles la santé cardiaque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des UCP dysfonctionnelles peuvent augmenter le risque de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre UCP et diabète ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des UCP peuvent influencer le métabolisme du glucose et le diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les UCP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'alimentation, le mode de vie sédentaire et le stress oxydatif sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge affecte-t-il la fonction des UCP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut altérer la fonction mitochondriale et des UCP."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques influencent-elles les UCP ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques peuvent affecter la production et la fonction des UCP."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire impacte-t-il les UCP ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut réduire l'activité des UCP et la santé mitochondriale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il les UCP ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction mitochondriale et des UCP."
}
}
]
}
]
}
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires ...
Leishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting millions of people, mainly in tropical countries, due to poor social conditions and low economic development. First-...
Previous clinical and basic studies have revealed that ginseng might have cardioprotective properties against anthracycline-induced cardiotoxicity (AIC). However, the underlying mechanism of ginseng a...
Fourteen drug-disease common targets were identified. Enrichment analysis showed that the AGE-RAGE in diabetic complications, fluid shear stress and atherosclerosis, and TNF signaling pathway were pot...
This study suggested that ginseng might exert their protective effects against AIC through the derived effector compounds beta-Sitosterol, Kaempferol and Fumarine by targeting CCNA2, STAT1, and ICAM1,...
Diabetes mellitus (DM) is a metabolic disorder disease that causes hyperglycemia conditions and associated with various chronic complications leading to mortality. Due to high toxicity of conventional...
Docking between ligand and FOXO1 receptor was carried out with Autodock4.2. For molecular dynamics simulations, the force fields of DNA.OL15, protein.ff14SB, gaff2, and tip3p were used....
During storage and processing, muscle proteins, e.g. myosin and myoglobin, will inevitably undergo degeneration, which is thus accompanied by quality deterioration of muscle foods. Some exogenous addi...
Cereblon (CRBN) is a substrate receptor of E3 ubiquitin ligase as well as the target of thalidomide and lenalidomide, plays a vital role in endogenous protein degradation. In this article, two series ...
Direct oral anticoagulants are an important and relatively new class of synthetic anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic disorders. However, they still have some l...
Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this study, HQSAR, CoMFA, CoMSIA and TopomerCoMFA m...
The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vac...
Oritavancin is a semi-synthetic lipoglycopeptide antibiotic primarily used to treat serious infections caused by Gram-positive bacteria. The aim of this study was to elucidate possible molecular targe...
Computational methods were used in this study which include target prediction, molecular docking, molecular dynamics simulation, pharmacokinetics prediction, and physiological-based pharmacokinetics (...
Oritavancin was moderately soluble in water and did not permeate the blood-brain barrier. Seven molecular targets were identified in humans. Molecular docking results showed highest binding affinity o...
This comprehensive computational study has provided invaluable insights into the pharmacological profile of Oritavancin, aiding its further development and optimization for clinical use....